FDA authorizes first revamp of COVID vaccines to target omicron

Indonesia Berita Berita

FDA authorizes first revamp of COVID vaccines to target omicron
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

Vials of the newly reformulated COVID-19 vaccine booster are being readied by Pfizer for distribution now that the Food and Drug Administration has authorized the shots for people 12 and older.Vials of the newly reformulated COVID-19 vaccine booster are being readied by Pfizer for distribution now that the Food and Drug Administration has authorized the shots for people 12 and older.

"The FDA has been planning for the possibility that the composition of the COVID-19 vaccines would need to be modified to address circulating variants. ... We have worked closely with the vaccine manufacturers to ensure the development of these updated boosters was done safely and efficiently," said Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research,."The FDA has extensive experience with strain changes for annual influenza vaccines.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NPRHealth /  🏆 144. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA authorizes first revamp of COVID vaccines to target omicronFDA authorizes first revamp of COVID vaccines to target omicronThe new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.
Baca lebih lajut »

FDA authorizes first revamp of COVID vaccines to target omicronFDA authorizes first revamp of COVID vaccines to target omicronThe new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.
Baca lebih lajut »

FDA Clears Updated COVID Boosters Targeting Newest VariantsFDA Clears Updated COVID Boosters Targeting Newest VariantsFederal regulators on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain.
Baca lebih lajut »

Pediatric cases rise as Biden administration prepares for rollout of new COVID vaccine boostersPediatric cases rise as Biden administration prepares for rollout of new COVID vaccine boostersExperts predict the FDA could authorize a new COVID-19 booster shot that includes a new formula aimed at targeting the latest omicron variants as early as this week.
Baca lebih lajut »

US clears updated COVID boosters targeting newest variantsUS clears updated COVID boosters targeting newest variants.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain.
Baca lebih lajut »

US clears updated COVID boosters targeting newest variantsUS clears updated COVID boosters targeting newest variants.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain.
Baca lebih lajut »



Render Time: 2025-04-04 04:03:47